( r> 5843780 6200806 ...)WARF is likely to hold on to stem cell patent rights
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
WARF is likely to hold on to stem cell patent rights
r>
| 5,843,780 | 6,200,806 | 7,029,913 | |||
| Application No. | 08/591,246 (`246) | 09/106,390 (`390) | 09/982,637 | ||
| Patent Issued | December 1, 1998 | March 13, 2001 | April 18, 2006 | ||
| Patent Filed | January 18, 1996 | June 26, 1998 | ...... Full article >>> '"/> Source:wistechnology.com By Grady Frenchick 04/12/07 Related biology technology : 1. Georgia stem cell company likely to stay put 2. Katrinas destruction likely to speed up electronic healthcare records adoption 3. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding 4. Wisconsin chooses likely vendors for BadgerNet 2 5. Storytelling makes a comeback in an unlikely place 6. Changes to U.S. patent law must nurture our culture of innovation 7. WARF questions relevancy of documents used to uphold patent challenge 8. Supreme Court limits foreign reach of U.S. patents 9. High court sends message on patent obviousness 10. Supreme Court ruling seen as blow to WARF stem cell patents 11. Heres why Wisconsins stem cell patents are being challenged Post Your Comments: (Date:11/19/2009)..., Most people would like to be able to charge the...kly and not too often. A recent discovery made by ...be-based supercapacitors that could do just this. ...sics Letters , Prabhakar Bandaru, a professor in t...ineering, along with graduate student Mark Hoefer,... (Date:11/19/2009)..., , BLAUVELT, N.Y., Nov. 19 ...at germ extract, responds to a press release issue...he Hungarian company for making false and self-ser... BioSciences. ,, Dr. Hidvegi stated from his o... claim that research on Avemar does not apply to A... (Date:11/19/2009)..., , BETHESDA, Md., Nov. 19 /PRNewswire-First... innovator in biotechnology for diabetes therapy, ...ing services to food, supplement, biotechnology an...sults of Tuesday,s Annual Meeting of Shareholders....orporated (Nasdaq: SPEX ) elected the following m... (Date:11/19/2009)..., , MONTREAL, Nov. 19 /PRNewswire/ - Aegera ...e first patient in a randomized Phase 2B study of ...stage development for multiple oncology indication...ized Phase 2 Study of the X-Linked Inhibitor of Ap...tion with High-dose Cytarabine and Idarubicin in A... Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2[0] Nanotube defects equal better energy and storage systems[0] American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor[0] Spherix Announces Results of Annual Shareholders Meeting[0] Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) ...M), a developer of follow-on biologics and biophar...nd questionnaire from the Chairman and,Ranking Mem...ttee on Health,on the possible development of legi...regulatory pathway., Sent to approximately 30 sta... and patient communities, the letter notes that th... ...date -, PRINCETON, N.J., April 10, 2008 Laureate...elopment and protein production,company, today ann...nufacturing agreement with Alopexx Pharmaceuticals...roduce Alopexx,s mAb F598 antibody under cGMP,cond...al trials, and later,for commercial production for... ...y become easier, thanks to chemical sensors being ... led by chemistry professor Theodore Goodson III h...ff signals that can be detected remotely---from a ...y described in the journal Nanotechnology and also...ional meeting of the American Chemical Society in ... Other Biology Technology:Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway 2Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway 3Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC 2Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC 3Safer, easier system for remote explosive detection 2(Date:11/23/2009)...hern California biomedical engineer and cardiologi...to help clinicians distinguish cardiac emergencies... manageable with drugs and lifestyle change. , A...the arteries feeding the heart, offer an inside vi...d vessels, often revealing deposits of a dangerous... (Date:11/23/2009)...te of General Medical Sciences (NIGMS), part of th...g $42.3 million for grants in scientific areas it ...loped the GO grant program to stimulate biomedical...the American Recovery and Reinvestment Act (Recove...mise to have a significant impact on a field of bi... (Date:11/23/2009)...sabona is Director of the Interuniversity Professo...rsity and the University of the Basque Country. Th...also has other experts such as researchers in the ...cialists in ethics. , The Interuniversity Profes...sities of Deusto and the Basque Country was create... Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 1Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 2Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 3Waters Drives Efficiency in the Clinical and Research Laboratory and Showcases New MassTrak Systems at AACC 2009 52119 4Promising new treatment for Alzheimers suggested based on Hebrew University research 9283 1Promising new treatment for Alzheimers suggested based on Hebrew University research 9283 2Slotted buses keep passengers cool 9279 1Slotted buses keep passengers cool 9279 2...ruggling with what humans have done to the modern ... according to Professor Greg Gibson,s recently pub... Between Our Genes and Modern Life Is Making Us Si...cal Sciences, suggests the increased rates of dise...due to human genes being unable to cope with the 2... ...MIPAS and GOME-2 instruments, scientists have for ...in the atmosphere. These new measurements will hel...-depleting species and to improve simulations of s...tion of bromine monoxide (BrO) in the atmosphere s...st observed in 2008 when scientists from the Karls... ...Biometric Technology In Support of the Warfighter ...pplications International Corporation (NYSE: SAI...ct by Sensor Technologies Incorporated (STI) to su... Command (CECOM) by providing operations and user ... (TBS). SAIC,s subcontract has a one-year base pe... Other Biology News:'It takes a genome: How a clash between our genes and modern life is making us sick' 2European satellites provide new insight into ozone-depleting species 2SAIC Awarded $115 Million Subcontract to Support Tactical Biometrics Systems (TBS) 2Equine TNF ALPHA from AbD Serotec REact 2 Buffer from Invitrogen Porcine TNF-alpha (TNFSF1A) ELISpot Development Kit from R&D Systems 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-Gal) from Molecular Probes (Invitrogen) Biology Products:
|
